Ann: Quarterly Activities Report and Appendix 4C, page-2

Increase in revenues 29%

BIG increase in collagen is very positive 611% Once approvals are received in China this will bring in BIG BIG revenues for Holista

M3 Machine good to go.

Looks like we are starting to tick a few boxes


Highlights
• Growth in quarterly sales across most of Holista’s core businesses
contributed to its improved Operating Cash Flow vs. pcp

• Quarterly unaudited sales increased 33% to $1.6m and 1H 2021
unaudited revenue up 29% to $3.6m

• Increase in forward orders of raw materials to buffer against COVID
disruptions negatively impacted on cash flows, but impact is
transitionary

• M3® cleared / exempted for use in Australia, Malaysia and Singapore
and NatshieldTM Nasal Balm is scheduled for launch before year end

• Positive outlook for all of Holista’s divisions with global trends
remaining supportive